re: Ann: Supplemental Information for Quarter... A small nugget of information that came out of the conference call:
Sharron G mentioned the company expects to have the clinical trials for the 3 new cancer indications registered with the FDA in late 2013 or early 2014.
Ann: Supplemental Information for Quarterly Confe, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
27.0¢ |
Change
-0.020(6.90%) |
Mkt cap ! $392.7M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 29.0¢ | 27.0¢ | $569.8K | 2.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 706076 | 27.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 100000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |